L.P. Bos

1.1k total citations
22 papers, 700 citations indexed

About

L.P. Bos is a scholar working on Surgery, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, L.P. Bos has authored 22 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in L.P. Bos's work include Acute Lymphoblastic Leukemia research (8 papers), Inflammatory Bowel Disease (7 papers) and Pregnancy and Medication Impact (5 papers). L.P. Bos is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Inflammatory Bowel Disease (7 papers) and Pregnancy and Medication Impact (5 papers). L.P. Bos collaborates with scholars based in Netherlands. L.P. Bos's co-authors include L.G.J.B. Engels, Lennard P. L. Gilissen, Luc J. J. Derijks, Paul Bus, P. M. Hooymans, R. Stockbrügger, Joost P.H. Drenth, P. M. Hooymans, Daniël W. Hommes and Sander J. H. van Deventer and has published in prestigious journals such as Clinica Chimica Acta, Alimentary Pharmacology & Therapeutics and Diseases of the Colon & Rectum.

In The Last Decade

L.P. Bos

22 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.P. Bos Netherlands 14 328 300 226 170 122 22 700
Peer de Graaf Netherlands 10 186 0.6× 293 1.0× 124 0.5× 91 0.5× 89 0.7× 13 496
Antonio López–Sanromán Spain 21 778 2.4× 229 0.8× 624 2.8× 369 2.2× 95 0.8× 68 1.2k
David Kotlyar United States 11 517 1.6× 162 0.5× 510 2.3× 301 1.8× 67 0.5× 29 1.0k
O Mickisch Germany 10 333 1.0× 38 0.1× 244 1.1× 225 1.3× 204 1.7× 13 720
LR Sutherland Canada 8 454 1.4× 147 0.5× 352 1.6× 185 1.1× 38 0.3× 17 644
Matteo Bramuzzo Italy 15 314 1.0× 48 0.2× 215 1.0× 150 0.9× 68 0.6× 83 609
Ondřej Hradský Czechia 14 303 0.9× 137 0.5× 212 0.9× 249 1.5× 34 0.3× 55 653
Viraj C. Kariyawasam Australia 17 485 1.5× 98 0.3× 379 1.7× 356 2.1× 21 0.2× 58 834
Marybeth Hopkins Canada 5 1.1k 3.2× 273 0.9× 848 3.8× 278 1.6× 186 1.5× 6 1.2k
David Ong Singapore 11 117 0.4× 51 0.2× 100 0.4× 123 0.7× 46 0.4× 18 360

Countries citing papers authored by L.P. Bos

Since Specialization
Citations

This map shows the geographic impact of L.P. Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.P. Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.P. Bos more than expected).

Fields of papers citing papers by L.P. Bos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.P. Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.P. Bos. The network helps show where L.P. Bos may publish in the future.

Co-authorship network of co-authors of L.P. Bos

This figure shows the co-authorship network connecting the top 25 collaborators of L.P. Bos. A scholar is included among the top collaborators of L.P. Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.P. Bos. L.P. Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilissen, Lennard P. L., Dennis R. Wong, L.G.J.B. Engels, et al.. (2012). Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Journal of Crohn s and Colitis. 6(6). 698–707. 56 indexed citations
2.
Rombout‐Sestrienkova, Eva, Fred Nieman, Brigitte A.B. Essers, et al.. (2011). Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial. Transfusion. 52(3). 470–477. 59 indexed citations
3.
Romberg‐Camps, Mariëlle, M. Hesselink, Leo J. Schouten, et al.. (2009). Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. Journal of Crohn s and Colitis. 3(2). 115–124. 60 indexed citations
4.
Gilissen, Lennard P. L., Luc J. J. Derijks, Ann Driessen, et al.. (2007). Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Digestive and Liver Disease. 39(2). 156–159. 39 indexed citations
5.
Derijks, Luc J. J., Lennard P. L. Gilissen, L.G.J.B. Engels, et al.. (2006). Pharmacokinetics of 6-Thioguanine in Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 28(1). 45–50. 47 indexed citations
6.
Gilissen, Lennard P. L., Jörgen Bierau, Luc J. J. Derijks, et al.. (2005). The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics. 22(7). 605–611. 53 indexed citations
7.
Derijks, Luc J. J., et al.. (2004). Some cases demonstrating the clinical usefulness of therapeutic drug monitoring in thiopurine-treated inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology. 16(7). 705–710. 18 indexed citations
8.
Gilissen, Lennard P. L., Luc J. J. Derijks, L.P. Bos, et al.. (2004). Therapeutic Drug Monitoring in???Patients with Inflammatory Bowel???Disease and Established Azathioprine Therapy. Clinical Drug Investigation. 24(8). 479–486. 26 indexed citations
9.
Derijks, Luc J. J., Lennard P. L. Gilissen, L.G.J.B. Engels, et al.. (2004). Pharmacokinetics of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 26(3). 311–318. 103 indexed citations
10.
Kouwen, Mariëtte C.A. van, et al.. (2003). Upper gastrointestinal endoscopy in patients aged 85 years or more. Results of a feasibility study in a district general hospital. Archives of Gerontology and Geriatrics. 37(1). 45–50. 23 indexed citations
11.
Mook, Walther van, et al.. (2001). The outcome of esophagogastroduodenoscopy (EGD) in asymptomatic outpatients with iron deficiency anemia after a negative colonoscopy. European Journal of Internal Medicine. 12(2). 122–126. 13 indexed citations
12.
Russel, M.G.V.M., Elisabeth Dorant, A. Volovics, et al.. (1998). High incidence of inflammatory bowel disease in The Netherlands. Diseases of the Colon & Rectum. 41(1). 33–40. 73 indexed citations
13.
Bos, L.P., et al.. (1995). An uncommon cause of anaemia in ulcerative colitis. The Netherlands Journal of Medicine. 47(1). 18–20. 1 indexed citations
14.
Drenth, Joost P.H., L.P. Bos, & L.G.J.B. Engels. (1990). Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Alimentary Pharmacology & Therapeutics. 4(4). 411–416. 43 indexed citations
15.
Engels, L.G.J.B., et al.. (1989). Clinical relevance of lysozyme in the faeces.. PubMed. 34(3-4). 174–81. 8 indexed citations
16.
Engels, L.G.J.B., et al.. (1987). Faecal lysozyme: determination, reference intervals and some data in gastro-intestinal disease. Clinica Chimica Acta. 167(2). 125–134. 11 indexed citations
17.
Bos, L.P., et al.. (1985). A new method for chemical analysis of faeces. Clinica Chimica Acta. 150(3). 197–203. 11 indexed citations
18.
Nubé, Menso J., et al.. (1982). Energy Intake and the Appearance of 5,8,11‐Eicosatrienoic Acid in Serum Lipids During Parenteral Nutrition Without Fat. Journal of Parenteral and Enteral Nutrition. 6(2). 134–139. 6 indexed citations
19.
Bos, L.P. & Irene T. Weterman. (1980). Total parenteral nutrition in Crohn's disease. World Journal of Surgery. 4(2). 163–165. 19 indexed citations
20.
Vloten, W.A. van & L.P. Bos. (1978). Skin Lesions in Acquired Zinc Deficiency due to Parenteral Nutrition. Dermatology. 156(3). 175–183. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peer de Graaf Breakdown of academic impact, for papers by Antonio López–Sanromán Breakdown of academic impact, for papers by David Kotlyar Breakdown of academic impact, for papers by O Mickisch Breakdown of academic impact, for papers by LR Sutherland Breakdown of academic impact, for papers by Matteo Bramuzzo Breakdown of academic impact, for papers by Ondřej Hradský Breakdown of academic impact, for papers by Viraj C. Kariyawasam Breakdown of academic impact, for papers by Marybeth Hopkins Breakdown of academic impact, for papers by David Ong
Rankless by CCL
2026